Argininosuccinic Aciduria

Search Trials
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Nitric Oxide Supplementation on Neurocognitive Functions in Patients With ASLD
Status:
Recruiting
Last Changed:
Aug 19, 2021
First Changed:
Feb 24, 2017
Disease(s):
Argininosuccinate Lyase Deficiency
Intervention(s):
Neo-ASAPlacebo
Nitric Oxide Supplementation in Argininosuccinic Aciduria
Status:
Completed
Last Changed:
Jan 18, 2020
First Changed:
Sep 30, 2014
Disease(s):
Argininosuccinic Aciduria
Intervention(s):
Nitric oxide supplementPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Arginine and Buphenyl in Patients With Argininosuccinic Aciduria (ASA), a Urea Cycle Disorder
Status:
Completed
Last Changed:
Jan 31, 2018
First Changed:
Jun 28, 2006
Disease(s):
Argininosuccinic Aciduria
Intervention(s):
Sodium PhenylbutyrateArginine

Connect. Empower. Inspire.